𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

✍ Scribed by David A. Reardon; Annick Desjardins; Katherine B. Peters; Sridharan Gururangan; John H. Sampson; Roger E. McLendon; James E. Herndon; Anuradha Bulusu; Stevie Threatt; Allan H. Friedman; James J. Vredenburgh; Henry S. Friedman

Publisher
Springer US
Year
2011
Tongue
English
Weight
736 KB
Volume
107
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab and daily temozolomide for r
Bevacizumab and daily temozolomide for recurrent glioblastoma
✍ Annick Desjardins; David A. Reardon; April Coan; Jennifer Marcello; James E. Her 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1021 KB

## Abstract ## BACKGROUND: The authors performed a phase 2 trial of combined protracted daily temozolomide and biweekly bevacizumab for patients with recurrent glioblastoma who had previously received radiation therapy and temozolomide. ## METHODS: There was no limit on the number of previous di